UNSPSC 51162301: Acetaminophen/chlorpheniramine/phenylephrine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162301 Acetaminophen/chlorpheniramine/phenylephrine/pyrilamine is a Commodity code, but recent state and local solicitations tagged to it involve parenteral pharmaceutical products and emergency-response medications rather than the specific combination-drug formulation the code nominally describes. The Washington State Department of Corrections solicited parenteral nutrition solutions, intravenous products, and controlled substances for incarcerated individuals under RFQQK13020, while Seminole County, Florida posted an IFB for naloxone and drug deactivation systems. The code shows minimal alignment with its nominal scope; the two opportunities represent distinct pharmaceutical supply and emergency-response categories that do not match the acetaminophen-based cold remedy the code names.

The issuing bodies are a state correctional agency and a county health authority, both focused on healthcare delivery to specific populations. The Washington DOC opportunity, with a response deadline of October 7, 2026, emphasizes rapid delivery (PN bags within 24 hours, other parenteral products within 8 hours), sophisticated preparation and monitoring, and multi-region award structure across eight facilities. The Seminole County opportunity, posted June 30, 2026 with a response date of July 26, 2023, sought annual volumes of 1,900 naloxone units and 800 deactivation systems with quarterly delivery. Geographic activity concentrates in Washington and Florida based on these recent postings. The code displays sparse recent activity with fundamental mismatch between its nominal pharmaceutical identity and the actual work being solicited; procurement professionals should verify whether a different UNSPSC code better describes their service line before investing in pursuit.